{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"MacroGenics, Inc."},"Symbol":{"label":"Symbol","value":"MGNX"},"Address":{"label":"Address","value":"9704 MEDICAL CENTER DRIVE, ROCKVILLE, Maryland, 20850, United States"},"Phone":{"label":"Phone","value":"+1 301 251-5172"},"Industry":{"label":"Industry","value":"Biotechnology: Pharmaceutical Preparations"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Macrogenics Inc is a biotechnology company focused on discovering and developing antibody-based therapeutics for the treatment of cancer. Its product includes MARGENZA, which is for the treatment of adult patients with metastatic HER2-positive breast cancer. The company's strategy includes leveraging partnerships with a therapeutic focus geared toward developing a broad portfolio of pipeline candidates. The company also targets autoimmune disorders and infectious diseases. The company's intellectual property is characterized by its patent use to protect the composition of its product candidates and the technology used to create them."},"CompanyUrl":{"label":"Company Url","value":"https://www.macrogenics.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Eric Risser","title":"Chief Operating Officer"},{"name":"Ezio Bonvini","title":"Chief Scientific Officer & Senior VP-Research"},{"name":"Scott E. Koenig","title":"President, Chief Executive Officer & Director"},{"name":"Stephen L. Eck","title":"Chief Medical Officer & SVP-Clinical Development"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}